Reaction
Liver Carcinoma Ruptured reporting signals
As of the last recalculation, Liver Carcinoma Ruptured appears in 249 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is SORAFENIB (PRR 214.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sorafenib | 44 | 214.9 | 215.3 |
| Durvalumab | 33 | 156.2 | 156.4 |
| Lenvatinib | 49 | 155.2 | 155.4 |
| Atezolizumab | 31 | 76.1 | 76.1 |
| Tolvaptan | 8 | 47.5 | 47.5 |
| Regorafenib | 5 | 36.7 | 36.7 |